Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor
Crossref DOI link: https://doi.org/10.1186/s12967-014-0265-3
Published Online: 2014-09-21
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kumai, Takumi
Oikawa, Kensuke
Aoki, Naoko
Kimura, Shoji
Harabuchi, Yasuaki
Celis, Esteban
Kobayashi, Hiroya
License valid from 2014-09-21